-
Aswathyraj S, Arunkumar G, Alidjinou EK, Hober D, 2016: Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy[J]. Med Microbiol Immunol, 205, 397-407. doi: 10.1007/s00430-016-0465-y
-
Bian L, Wang Y, Yao X, Mao Q, Xu M, Liang Z, 2015: Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide[J]. Expert Rev Anti Infect Ther, 13, 1061-1071. doi: 10.1586/14787210.2015.1058156
-
Bian L, 2019: Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems[J]. Expert Rev Anti Infect Ther, 17, 233-242. doi: 10.1080/14787210.2019.1585242
-
Caine EA, Osorio JE, 2017: In vivo imaging with bioluminescent enterovirus 71 allows for real-time visualization of tissue tropism and viral spread[J]. J Virol, 91, e01759-16. doi: 10.1128/jvi.01759-16
-
Chen P, 2012: Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B2[J]. J Biol Chem, 287, 6406-6420. doi: 10.1074/jbc.M111.301622
-
Davia JL, 2011: Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses[J]. Pediatr Dermatol, 28, 1-5. doi: 10.1111/j.1525-1470.2010.01161.x
-
Deng C, Li X, Liu S, Xu L, Ye H, Qin CF, Zhang B, 2015: Development and characterization of a clinical strain of Coxsackievirus A16 and an eGFP infectious clone[J]. Virol Sin, 30, 269-276. doi: 10.1007/s12250-015-3610-7
-
Fu X, Wan Z, Li Y, Hu Y, Jin X, Zhang C, 2019: National epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016[J]. Virol Sin, , -. doi: 10.1007/s12250-019-00169-2
-
Herold J, Andino R, 2000: Poliovirus requires a precise 5′ end for efficient positive-strand RNA synthesis[J]. J Virol, 74, 6394-6400. doi: 10.1128/JVI.74.14.6394-6400.2000
-
Kaplan G, Racaniello VR, 1988: Construction and characterization of poliovirus subgenomic replicons[J]. J Virol, 62, 1687-1696. doi: 10.1128/JVI.62.5.1687-1696.1988
-
Klein MH, 2015: EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines[J]. Expert Rev Vaccines, 14, 337-340. doi: 10.1586/14760584.2015.993385
-
Li R, 2014: An inactivated enterovirus 71 vaccine in healthy children[J]. N Engl J Med, 370, 829-837. doi: 10.1056/NEJMoa1303224
-
Li Z, 2016: Identification of a nucleotide in 5′ untranslated region contributing to virus replication and virulence of Coxsackievirus A16[J]. Sci Rep, 6, 20839-. doi: 10.1038/srep20839
-
Liu CC, 2016: Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles[J]. Antiviral Res, 129, 58-66. doi: 10.1016/j.antiviral.2016.02.008
-
Liu Q, 2019: Construction and characterization of an infectious cDNA clone of coxsackievirus A10[J]. Virol J, 16, 98-. doi: 10.1186/s12985-019-1201-1
-
Staring J, van den Hengel LG, Raaben M, Blomen VA, Carette JE, Brummelkamp TR, 2018: KREMEN1 is a host entry receptor for a major group of enteroviruses[J]. Cell Host Microbe, 23, 636-643. doi: 10.1016/j.chom.2018.03.019
-
Tan CW, Tee HK, Lee MH, Sam IC, Chan YF, 2016: Enterovirus A71 DNA-launched infectious clone as a robust reverse genetic tool[J]. PLoS One, 11, e0162771-. doi: 10.1371/journal.pone.0162771
-
Tapparel C, Siegrist F, Petty TJ, Kaiser L, 2013: Picornavirus and enterovirus diversity with associated human diseases[J]. Infect Genet Evol, 14, 282-293. doi: 10.1016/j.meegid.2012.10.016
-
Teterina NL, Pinto Y, Weaver JD, Jensen KS, Ehrenfeld E, 2011: Analysis of poliovirus protein 3A interactions with viral and cellular proteins in infected cells[J]. J Virol, 85, 4284-4296. doi: 10.1128/JVI.02398-10
-
van der Schaar HM, 2016: Illuminating the sites of enterovirus replication in living cells by using a split-GFP-tagged viral protein[J]. mSphere, 1, e00104-16.
-
Volle R, 2019: High permissiveness for genetic exchanges between enteroviruses of species A, including enterovirus 71, favors evolution through intertypic recombination in Madagascar[J]. J Virol, , -. doi: 10.1128/JVI.01667-18
-
Wang X, Shen C, Chen T, Lan K, Huang Z, Zhang Y, Liu Q, 2016: Improved plasmid-based recovery of coxsackievirus A16 infectious clone driven by human RNA polymerase I promoter[J]. Virol Sin, 31, 339-341. doi: 10.1007/s12250-016-3716-6
-
Watson SJ, Welkers MR, Depledge DP, Coulter E, Breuer JM, de Jong MD, Kellam P, 2013: Viral population analysis and minority-variant detection using short read next-generation sequencing[J]. Philos Trans R Soc Lond B Biol Sci, 368, 20120205-. doi: 10.1098/rstb.2012.0205
-
Yang B et al. (2017) Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine Euro Surveill 22
-
Yang L, 2015: Construction and characterization of an infectious clone of coxsackievirus A6 that showed high virulence in neonatal mice[J]. Virus Res, 210, 165-168. doi: 10.1016/j.virusres.2015.08.002
-
Yang YT, 2016: Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology[J]. Antiviral Res, 132, 225-232. doi: 10.1016/j.antiviral.2016.06.014
-
Yuan M, 2018: Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases[J]. Virol J, 15, 1-. doi: 10.1186/s12985-017-0913-3
-
Zhu F, 2014: Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China[J]. N Engl J Med, 370, 818-828. doi: 10.1056/NEJMoa1304923